ZA200405853B - Use of adapalene for the treatment of dermatological disorders - Google Patents
Use of adapalene for the treatment of dermatological disordersInfo
- Publication number
- ZA200405853B ZA200405853B ZA200405853A ZA200405853A ZA200405853B ZA 200405853 B ZA200405853 B ZA 200405853B ZA 200405853 A ZA200405853 A ZA 200405853A ZA 200405853 A ZA200405853 A ZA 200405853A ZA 200405853 B ZA200405853 B ZA 200405853B
- Authority
- ZA
- South Africa
- Prior art keywords
- adapalene
- treatment
- dermatological disorders
- dermatological
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0203070A FR2837101B1 (en) | 2002-03-12 | 2002-03-12 | USE OF 6- [1-ADAMANTYL) -4-METHOXYPHENYL] -2- NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200405853B true ZA200405853B (en) | 2008-10-29 |
Family
ID=27772059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200405853A ZA200405853B (en) | 2002-03-12 | 2004-07-22 | Use of adapalene for the treatment of dermatological disorders |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR101007161B1 (en) |
AR (1) | AR038924A1 (en) |
FR (1) | FR2837101B1 (en) |
ZA (1) | ZA200405853B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100798853B1 (en) * | 2005-02-15 | 2008-01-28 | (주)한국스티펠 | Pharmaceutical composition for the prevention and treatment of vitiligo with retinoids as an active ingredient |
FR2901701B1 (en) * | 2006-05-31 | 2010-10-29 | Galderma Res & Dev | COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE FILMOGENIC AGENT, PROCESSES FOR THEIR PREPARATION, AND USES THEREOF |
FR2903603B1 (en) | 2006-07-13 | 2009-03-20 | Galderma Res & Dev S N C Snc | COMBINATION OF ADAPALENE AND BENZOLEO PEROXIDE IN THE TREATMENT OF ACNE |
EP2097075A1 (en) * | 2006-11-20 | 2009-09-09 | Galderma Research & Development, S.N.C. | Use of adapalene for modulating the expression of cd1d or il-10 |
EP2097076A1 (en) * | 2006-11-20 | 2009-09-09 | Galderma Research & Development, S.N.C. | Use of adapalene for modulating the expression of il-1ra |
JP2013518920A (en) | 2010-02-09 | 2013-05-23 | ガルデルマ・リサーチ・アンド・デヴェロップメント | Dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne with reduced post-inflammatory pigmentation in non-Caucasian races |
EP2563357B1 (en) | 2010-04-29 | 2018-10-17 | Galderma Research & Development | Adapalene 0.3% for use in a method for treating scars |
US20150126608A1 (en) | 2012-05-25 | 2015-05-07 | Galderma Research & Development | Treatment of preadolescent moderate acne vulgaris |
US10653659B2 (en) | 2014-11-20 | 2020-05-19 | Galderma S.A. | Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne |
KR102486502B1 (en) * | 2015-09-15 | 2023-01-09 | 주식회사 엘지생활건강 | Soluble microneedle patch for delivery of anti-acne drug |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU85849A1 (en) * | 1985-04-11 | 1986-11-05 | Cird | BENZONAPHTHALENIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THE PHARMACEUTICAL AND COSMETIC FIELDS |
FR2730930B1 (en) * | 1995-02-27 | 1997-04-04 | Oreal | USE OF NO-SYNTHASE INHIBITORS TO REDUCE THE IRRITANT SKIN EFFECT OF PRODUCTS USED IN THE COSMETIC OR PHARMACEUTICAL FIELD |
-
2002
- 2002-03-12 FR FR0203070A patent/FR2837101B1/en not_active Expired - Fee Related
-
2003
- 2003-03-11 AR ARP030100823A patent/AR038924A1/en not_active Application Discontinuation
- 2003-03-12 KR KR1020047014228A patent/KR101007161B1/en not_active Expired - Lifetime
-
2004
- 2004-07-22 ZA ZA200405853A patent/ZA200405853B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR101007161B1 (en) | 2011-01-12 |
FR2837101B1 (en) | 2004-07-02 |
AR038924A1 (en) | 2005-02-02 |
KR20040111394A (en) | 2004-12-31 |
FR2837101A1 (en) | 2003-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
IL160389A0 (en) | Use of flibanserin for the treatment of sexual disorders | |
GB0201850D0 (en) | Therapeutic treatment | |
GB0216321D0 (en) | Therapeutic treatment | |
IL175055A0 (en) | Combinations useful for the treatment of neuronal disorders | |
IL209842A0 (en) | Compounds for the treatment of metabolic disorders | |
IL163725A0 (en) | Administration of agents for the treatment of inflammation | |
PL378108A1 (en) | Combination therapy for the treatment of immunoinflammatory disorders | |
AU2003228819A8 (en) | Combinations for the treatment of inflammatory skin disorders | |
AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
AU2003286728A8 (en) | Compounds for the treatment of metabolic disorders | |
GB0223367D0 (en) | Therapeutic treatment | |
GB0213869D0 (en) | The treatment of pain | |
ZA200405853B (en) | Use of adapalene for the treatment of dermatological disorders | |
GB0219660D0 (en) | Therapeutic use | |
IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
GB0223854D0 (en) | Therapeutic treatment | |
AU2003303217A8 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
GB0210464D0 (en) | Therapeutic treatment | |
ZA200505996B (en) | Combination therapy for the treatment of immunoinflammatory disorders | |
AU2003209542A8 (en) | Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
GB0201025D0 (en) | The treatment of degenerative diseases | |
AU2003274885A1 (en) | Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders | |
HRP20041159A2 (en) | Combination for the treatment of airway disorders |